Share and Follow
Temporary tattoos may soon have a significant role beyond children’s party favors.
Researchers in Canada have crafted a temporary “smart tattoo” designed to identify melanomas before they become visible and potentially dangerous.
Their findings, detailed in the recent issue of Nature Sensors, highlight the effectiveness of SMEAR-ULM, a technology that detects early-stage skin cancer by assessing temperature changes on the skin’s surface.
“We aim to offer a minimally invasive method for identifying very small yet aggressive melanomas,” explained Jinyang Liang, the study’s senior author.
Melanoma, often referred to as a “black tumor,” can manifest as a new or evolving mole, or a spot with an unusual shape, border, or color. These spots can present in shades of brown, black, or sometimes pink, red, or white.
Melanoma is considered the most dangerous type of skin cancer because it has a high potential to metastasize to other parts of the body if not identified and treated early.
The current protocol for diagnosing melanoma hinges on visual examinations and biopsies, the latter of which is invasive and, in some cases, unnecessary.
Researchers are hopeful that, when applied to suspicious lesions, this new technology could reduce the need for biopsies and improve diagnostic accuracy.
“Because of their small size, the melanomas are usually excluded from clinical visual inspection, which leaves the threat unwatched. We want to detect them so that intervention can be made as soon as possible,” said Liang.
The temporary patch contains pain-free microneedles that deposit nanoparticles beneath the skin that function as microscopic thermometers.
When exposed to near-infrared light, the nanoparticles emit visible light that depends on local temperature.
Researchers note that cancer cells consume more oxygen and emit more heat than healthy cells, a temperature difference that the patch can detect and visually signal.
Researchers shared that the patch establishes skin temperature as a precise diagnostic biomarker for early-stage melanoma.
“We capture all the necessary information for an instantaneous temperature map in a single shot, which makes the method fast and robust to continuously monitor abnormal thermal responses in small melanomas,” said first author Yingming Lai.
The team tested the technology on mice and successfully detected micro‑melanomas as young as 4 days old, a stage at which melanomas are too small to be detected via conventional imaging techniques.
A breakthrough like this could not come soon enough.
The Skin Cancer Foundation predicts that 234,680 cases of melanoma will be diagnosed in the US in 2026, a staggering 10.6% increase from 2025.
Of these projected cases, 122,680 will be noninvasive, or confined to the top layer of skin, while 112,000 cases will be invasive, penetrating the epidermis into the skin’s second layer.
In noninvasive cases where melanoma hasn’t spread beyond the skin, 99 out of 100 patients will survive for five years after diagnosis, according to the American Cancer Society.
That number drops significantly, to just 35 out of 100 patients, when the cancer has spread to distant parts of the body, like the lungs or liver.
Unfortunately, these latest figures align with a troubling trend. In the past decade, the number of new invasive melanoma cases diagnosed annually increased by 46.6%.
Things to look for are the “ABCDEs” of melanoma — asymmetry, border irregularity, color variability, diameter greater than 6 millimeters, roughly the size of a pencil eraser.
The risk of melanoma also increases with age. The average age of Americans diagnosed is 66, but it’s one of the most common cancers in people under 30 — especially young women.
Other risk factors include being male, having several moles, a personal or family history of the disease and a history of blistering sunburns, particularly in childhood. People who spend a lot of time outdoors may also face a higher risk due to increased sun exposure.